Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-07 6:00 pm Sale |
2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,242,245 4.950% |
-214,428 (-14.72%) |
Filing History |
| 2024-02-13 5:34 pm Sale |
2024-02-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,456,673 5.830% |
-277,485 (-16.00%) |
Filing History |
| 2023-11-03 5:03 pm Purchase |
2023-10-25 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,734,158 6.500% |
1,734,158 (New Position) |
Filing History |
| 2023-08-04 4:41 pm Sale |
2023-07-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 3,653,120 14.600% |
-1,582,836 (-30.23%) |
Filing History |
| 2023-06-02 5:00 pm Sale |
2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 0 0.000% |
-3,441,661 (Position Closed) |
Filing History |
| 2023-05-23 4:50 pm Unchanged |
2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.100% |
0 (Unchanged) |
Filing History |
| 2023-03-09 5:15 pm Purchase |
2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.200% |
2,200 (+0.06%) |
Filing History |
| 2023-02-14 11:36 am Purchase |
2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 5,235,956 17.000% |
4,468 (+0.09%) |
Filing History |
| 2022-11-21 06:15 am Unchanged |
2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing History |
| 2022-11-02 11:58 am Unchanged |
2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing History |
| 2022-07-19 5:30 pm Purchase |
2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
210,000 (+6.50%) |
Filing History |
| 2022-06-10 2:18 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 5,231,488 17.100% |
5,231,488 (New Position) |
Filing History |
| 2022-02-14 3:01 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
H&S INVESTMENTS I LP | 4,441,624 14.500% |
4,441,624 (New Position) |
Filing History |
| 2022-02-10 5:15 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,229,461 10.600% |
577,618 (+21.78%) |
Filing History |
| 2021-02-18 4:15 pm Purchase |
2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 2,651,843 8.700% |
2,651,843 (New Position) |
Filing History |
| 2021-02-16 10:59 am Purchase |
2021-02-03 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Peyer James | 4,690,153 15.300% |
4,690,153 (New Position) |
Filing History |